Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Arcuturs Reports Regulatory Approval To Proceed With Phase 2 Study Of ARCT-810 mRNA Therapeutic Candidate For Ornithine Transcarbamylase Deficiency


Benzinga | Jul 28, 2021 08:32AM EDT

Arcuturs Reports Regulatory Approval To Proceed With Phase 2 Study Of ARCT-810 mRNA Therapeutic Candidate For Ornithine Transcarbamylase Deficiency






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC